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Abstract 
Purpose: Intensive care patients have increased risk of death and their care is expensive. We investigated whether 
risk-adjusted mortality and resources used to achieve survivors change over time and if their variation is associated 
with variables related to intensive care unit (ICU) organization and structure.
Methods: Data of 207,131 patients treated in 2008–2017 in 21 ICUs in Finland, Estonia and Switzerland were 
extracted from a benchmarking database. Resource use was measured using ICU length of stay, daily Therapeutic 
Intervention Scoring System Scores (TISS) and purchasing power parity-adjusted direct costs (2015–2017; 17 ICUs). 
The ratio of observed to severity-adjusted expected resource use (standardized resource use ratio; SRUR) was calcu-
lated. The number of expected survivors and the ratio of observed to expected mortality (standardized mortality ratio; 
SMR) was based on a mortality prediction model covering 2015–2017. Fourteen a priori variables reflecting structure 
and organization were used as explanatory variables for SRURs in multivariable models.
Results: SMR decreased over time, whereas SRUR remained unchanged, except for decreased TISS-based SRUR. 
Direct costs of one ICU day, TISS score and ICU admission varied between ICUs 2.5–5-fold. Differences between indi-
vidual ICUs in both SRUR and SMR were up to > 3-fold, and their evolution was highly variable, without clear associa-
tion between SRUR and SMR. High patient turnover was consistently associated with low SRUR but not with SMR.
Conclusion: The wide and independent variation in both SMR and SRUR suggests that they should be used together 
to compare the performance of different ICUs or an individual ICU over time.
Keywords: Intensive care unit, Hospital mortality, Health resources, Resource allocation, Health care benchmarking, 
Cost control
Introduction
The primary goal of intensive care is to prevent death and 
disability. Intensive care requires extensive resources. In 
the United States, for example, intensive care costs rep-
resent 0.7% of the gross national product [1]. Since sever-
ity of illness influences the risk of death, severity scoring 
systems have been created for comparison of mortality 
outcomes [2–7]. Standardized mortality ratio (SMR; the 
ratio between observed and predicted, severity-adjusted 
mortality) is widely used to compare the performance of 
individual intensive care units (ICUs). Several-fold differ-
ences in mortality, adjusted for severity of illness, have 
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been reported between ICUs both internationally and 
within countries [6, 8–10]. Much less is known about 
resources needed to produce survivors of critical illness. 
Using data from the SAPS-3 database, several-fold differ-
ences in severity-adjusted ICU resources needed to pro-
duce hospital survivors (standardized resource use ratio, 
SRUR; SRUR > 1 indicates more resources than expected 
used to produce survivors) were observed when ICU 
length of stay (LOS) was used as a surrogate for resource 
use [11]. The variation of SRUR was much greater than 
that of SMR. Such variation may be due to differences in 
health care systems and economies, or LOS as sole sur-
rogate for resource use [11, 12]. A better understand-
ing of variation in SRUR may help to optimize resource 
allocation.
The aim of this study was to evaluate variation in SRUR 
and SMR over time, factors related to this variation, and 
to analyze cost structures and ICU organization in Fin-
land, Estonia, and Switzerland.
Materials and methods
We used data from 2008 to 2017, extracted into an 
anonymized database from a benchmarking database 
[13]. The study protocol, database contents and data 
management process were approved by the National 
Institute of Health and Welfare, Finland (Decision 
THL/1524/5.05.00/2017 and THL/1173/05.00/2018). 
According to regulations in Finland, Estonia, and Swit-
zerland, no ethics committee approval was needed.
The Finnish Intensive Care Consortium (FICC) consists 
of all adult ICUs in Finland except one neurosurgical ICU 
(19 of 21 ICUs included), and the ICUs of one university 
hospital in Estonia (100% of university ICU admissions 
and 16% all ICU admissions in Estonia) and one in Swit-
zerland (33% of all university hospital ICU admissions 
and 11% of all ICU admissions in Switzerland). Services 
with subunits but sharing resources were considered as 
one ICU (two university hospitals). All ICUs were mul-
tidisciplinary. The ICUs were a priori categorized as uni-
versity hospital ICU (tertiary referral center function), 
large, or small non-university ICUs (large with primary 
referral population at least 120,000 inhabitants and at 
least 6 beds, others small).
Data on diagnosis, severity of illness, care interven-
tions, physiologic, administrative, and hospital outcome 
data from all ICU admissions are extracted from elec-
tronic patient records (manually from paper in Estonia) 
into a validation software. Using logical rules, median 
filtering and graphic displays to ensure data quality, each 
admission is validated by trained ICU nurse datamanag-
ers or intensivists before transfer to the FICC database.
Study populations
Overall population included all resources used by the 
participating ICUs (Fig.  1). For hospital survivor count, 
readmissions were excluded (SRUR population). Cardiac 
surgery patients and readmissions were excluded from 
SMR calculation (SMR population). In both SRUR and 
SMR populations, admissions missing hospital outcome 
were excluded. Cost analyses were done for 17 ICUs and 
years 2015–2017 of the Overall and SRUR populations.
Resource use
Resource use was assessed using ICU LOS, daily col-
lected Therapeutic Intervention Scoring System-76 
(TISS) Scores [14] including 17 additional items (Supple-
mentary Information; referred throughout using prefix 
“e”: eTable1), and direct ICU costs (salaries, drugs, fluids, 
disposables). The TISS score ranks ICU activities accord-
ing to intensity and resource use; the sum of daily scores 
indicates total resource use. First, all units were included 
using ICU LOS- and TISS-based SRUR for description 
of changes in SRUR and SMR in 2008–2017. Second, an 
analysis using direct costs was performed for 2015–2017. 
ICUs without clear cost allocation were excluded. To 
include physicians’ salaries allocated to other budgets or 
simultaneously covering other services, physician staff 
organization, rotations, in-house and on-call coverage 
was clarified with each ICU leader and costs were allo-
cated based on consensus time estimates (eTable 2).
Calculation of SRUR 
All yearly ICU admissions were stratified according to 
SAPS-II scores (0–9, 10–19, …, 80–89, > 90). First, in 
each stratum, the sums of all LOS days and TISS scores 
(Overall population) were divided by the number of 
hospital survivors (SRUR population). This was the 
expected resource use (as LOS/TISS)/survivor for each 
stratum. Second, for each ICU, the expected resource 
use for each SAPS-II stratum was calculated as (num-
ber of survivors)*(expected LOS/TISS per survivor) and 
the expected total resource use as the sum of expected 
resource use in all SAPS-II strata. Third, the SRUR LOS 
and SRUR TISS were calculated as the ratio of observed to 
Take‑home message 
Severity of illness adjusted hospital mortality in intensive care 
patients has substantially decreased over time, without an increase 
in severity-adjusted resources use. The wide and independent vari-
ation in both mortality and resource use suggests that both should 
be used together and adjusted for severity of illness to compare 
performance of different ICUs or an individual ICU over time.
expected total resource use, using LOS and TISS, respec-
tively (Supplementary Information: ”example of SRUR 
calculation”).
For SRUR using direct costs (years 2015–2017, 17 
ICUs), the mean costs of one ICU LOS day and TISS 
point were calculated as the sum of direct costs for all 
admissions divided by the sum of LOS days and TISS 
points, respectively. A fixed exchange rate of 1.00 Swiss 
franc to 1.09 Euros was used, without inflation adjust-
ment. The expected costs to produce a hospital survivor 
in each SAPS-II stratum were calculated as (expected 
resource use LOS/TISS per survivor)*(mean cost of LOS/
TISS). For each ICU, the sum of expected direct costs in 
all strata (number of survivors*expected costs to produce 
a hospital survivor) was the expected total direct cost. 
The cost-based SRUR for each ICU was calculated as 
observed/expected total direct costs based on LOS (cost-
SRUR LOS) and TISS (costSRUR TISS). The differences in 
costs between countries were adjusted using the purchas-
ing power parity (PPP) provided by the OECD [15], using 
PPP = 1.0 for Finland (Supplementary Information: “cost 
adjustment using purchasing power parity”). All costs are 
PPP-adjusted.
Structure and process
Each ICU leader provided the average number of beds, 
physicians (including rotations, in-house and on-call cov-
erage), and nursing staff, organization type (independ-
ent/part of another department), availability of an ICU 
specialist 24/7, availability of a medical emergency team 
(MET), and presence of other ICU/intermediate care 
units in campus.
SMR
SMR was calculated for each ICU as observed/predicted 
hospital mortality. The predicted probability of hospital 
mortality was calculated using a recent prediction model 
customized for FICC, based upon 61,224 ICU admis-
sions between 2015 and 2017 (https:// doi. org/ 10. 31219/ 
osf. io/ rb62v). Briefly, the risk prediction model accounts 
for age, a modified SAPS-II score (without age, admission 
type), patient pre-admission functional status, APACHE-
III diagnosis and admission type (emergency/elective). 
The predictive performance of the model in the different 
cohorts is shown in eTable 3. Generally, the discrimina-
tion and calibration abilities were very good.
Fig. 1 Flowchart showing study populations and exclusions
Statistical analysis
We described the study population by frequencies 
(n), percentages (%), means, standard deviations (SD), 
median and percentiles. Differences across ICU cat-
egories were tested by an analysis of variance and a chi-
squared test. We used box plots to describe SRUR and 
SMR by calendar year. We used Gaussian linear regres-
sion models to investigate the effect of SMR on SRUR LOS 
and SRUR TISS and the effect of SRUR LOS and SRUR TISS 
and SMR on costSRUR LOS and costSRUR TISS. We used 
hierarchical regression models to investigate ICU-related 
factors associated with SRUR LOS, SRUR TISS, costSRUR LOS 
and costSRUR TISS and to investigate an interaction effect 
between SAPS-strata and ICU category on SRUR and 
SMR variation for a hypothesized case-mix effect (Sup-
plementary information: “details of regression models”). 
We a priori selected the following ICU-related variables: 
ICU category (University, small/large non-University), 
cardiac surgery in hospital (yes/no), neurosurgery in 
hospital (yes/no), nurses/bed, nurses/physician, total 
number of beds, readmissions/total admissions, admis-
sions/bed, specialist availability 24/7 (yes/no), medi-
cal emergency team (MET; yes/no), physician full-time 
equivalents (FTE)/bed (Supplementary Information: “cal-
culation of physician full-time equivalents”), organization 
type (independent or not), median SAPS-II and SMR. 
We used bivariable models (one of the above variables 
adjusted for calendar year) and multivariable models (all 
of the above variables adjusted for calendar year). ICU 
category was only used in bivariable models, because of 
its high correlation with other variables. Continuous var-
iables were standardized (centered and expressed per one 
standard deviation increase) and relative risk estimates 
(RR) reported with 95% CI. Analyses with ICU-category 
stratification were justified by an interaction (two-sided p 
value p < 0.05) between SAPS-II and ICU category. Fixed 
effect estimates for SAPS-II strata and calendar years 
are expressed as estimated SRUR and SMR changes with 
95% CI. ICU-specific random effects with 95% CI were 
used to assess variation across ICUs, by ICU category. All 
analyses are performed in R version 4.0.2 (R Team Core. 
R: A language and environment for statistical computing, 
Vienna, Austria. R Foundation for Statistical Computing).
Results
ICU and admission characteristics
From 2008 to 2017, 207,131 admissions were included 
from 21 units (8 university, 7 large non-university, 
and 6 small non-university ICUs; Fig.  1). Data for all 
10  years were available from 18 hospitals (6 university, 
6 large non-university, 6 small non-university ICUs), 
whereas due to structural or organizational changes, two 
university ICUs provided data for 2013–2017 and one 
non-university hospital for 2008–2013 only. Direct costs 
for 2015–2017 for costSRUR LOS and costSRUR TISS were 
available for 17 ICUs (8 university, 4 large non-university, 
5 small non-university ICUs).
The admission characteristics across ICU catego-
ries were different (Table  1; all p values < 0.001, except 
p = 0.02 for gender). The non-university ICUs treated 
predominantly emergency (> 90%) and non-surgical 
admissions (74%) with higher median SAPS-II, whereas 
the university ICUs had more elective (34%) and surgical 
admissions (53%) and the shortest median LOS (key unit 
characteristics in eTable  2). The university hospitals in 
the three countries provided 71% of all ICU admissions, 
and the two university hospital ICUs in Estonia and Swit-
zerland 45% of all university hospital admissions.
Analysis of direct costs 2015–2017
The mean direct costs for one ICU admission, ICU day 
and TISS point ranged annually from €6487 to €6774, 
from €2082 to €2125 and from €51 to €52, respectively 
(eTable 4). The mean direct costs for achieving one hos-
pital survivor were €7183–€7500. The variation between 
ICUs was high in all cost variables, more than 2.5-fold in 
costs of 1  ICU day and one TISS point, and more than 
5-fold in costs of admission and costs for achieving one 
hospital survivor. The costs/survivor increased exponen-
tially with increasing SAPS-II category (p < 0.001; eTa-
ble  5; eFigure  1), and the variation between ICUs was 
high. Salary costs contributed 81 ± 6% (mean ± SD) to 
total direct costs, and the remaining 19 ± 6% were costs 
for drugs, fluids and disposables (eFigures 2, 3).
Evolution of SRUR and SMR over time
From 2008 to 2017, SMR decreased over time (p < 0.001; 
Fig. 2, left panel). There was no overall change over time 
in median SAPS-II score (range 31–34; eFigure  4). The 
relative contribution of the highest SAPS strata decreased 
(calendar year*SAPS stratum interaction p < 0.001). Fun-
nel plots indicated no unexpected SMR variation in rela-
tion to number of admissions (eFigure 5).
The resources needed to produce one survivor 
decreased by 0.7%, 95%CI (1.2–0.2%), when assessed with 
SRUR TISS (p = 0.02; Fig. 2, left panel), whereas there was 
no change in SRUR LOS (p = 0.27; Fig.  2, left panel). The 
costSRUR LOS and costSRUR TISS (years 2015–2017) did 
not change (Fig. 2, right panel). We found an interaction 
between ICU categories and SAPS strata (all p < 0.001; 
SAPS stratified SRUR LOS, SRUR TISS and SMR in each 
ICU category eFigure 6). Non-university ICUs had wider 
ranges of SMR and smaller ranges of SRURs (eFigure 7).
Relationship between SRUR and SMR and between SRUR 
and costSRUR 
We found no association between the SRUR LOS, SRUR 
TISS, costSRUR LOS or costSRUR TISS with SMR, except 
for SRUR LOS from 2008 to 2010 and in 2013 (Fig.  3, 
eFigure 8, eTables 6 and 7). An increase in costSRUR LOS 
(or costSRUR TISS) was associated with an increase in 
SRUR LOS (or SRUR TISS) (Fig.  4, eTable  7). The findings 
were similar for different ICU categories (eFigures  9, 
10).
Table 1 Admission characteristics by intensive care unit category and overall
SAPS-II simplified acute physiology score; LOS length of stay in the intensive care unit; TISS Therapeutic Intervention Scoring System; TISS EXT score sum includes the 
additional items described in the “Methods”
University 








 Mean (SD) 59.8 (17.5) 58.3 (19.7) 61 (18.6) 59.7 (18.1)
 Median [Min, Max] 63 [0, 100] 63 [0, 102] 64 [0, 101] 63 [0, 102]
Gender
 Male 91,789 (62.3%) 22,957 (63.2%) 14,674 (62.3%) 129,420 (62.5%)
 Female 55,435 (37.6%) 13,386 (36.8%) 8856 (37.6%) 77,677 (37.5%)
 Missing 27 (0%) 0 (0%) 7 (0%) 34 (0%)
Type of admission
 Readmission 11,040 (7.5%) 2402 (6.6%) 1387 (5.9%) 14,829 (7.2%)
 First admission 136,211 (92.5%) 33,941 (93.4%) 22,150 (94.1%) 192,302 (92.8%)
Treatment type
 Elective 50,374 (34.2%) 2184 (6%) 2109 (9%) 54,667 (26.4%)
 Emergency 96,877 (65.8%) 34,159 (94%) 21,428 (91%) 152,464 (73.6%)
Surgical treatment
 Non-surgical 69,147 (47%) 27,692 (76.2%) 16,701 (71%) 113,540 (54.8%)
 Surgical 78,104 (53%) 8651 (23.8%) 6836 (29%) 93,591 (45.2%)
SAPS-II score stratum
 0–9 6467 (4.4%) 755 (2.1%) 517 (2.2%) 7739 (3.7%)
 10–19 22,904 (15.6%) 4199 (11.6%) 2970 (12.6%) 30,073 (14.5%)
 20–29 41,601 (28.3%) 8476 (23.3%) 6127 (26%) 56,204 (27.1%)
 30–39 31,933 (21.7%) 8404 (23.1%) 5631 (23.9%) 45,968 (22.2%)
 40–49 19,208 (13%) 6190 (17%) 3576 (15.2%) 28,974 (14%)
 50–59 12,114 (8.2%) 3829 (10.5%) 2175 (9.2%) 18,118 (8.7%)
 60–69 7277 (4.9%) 2381 (6.6%) 1360 (5.8%) 11,018 (5.3%)
 70–79 3352 (2.3%) 1198 (3.3%) 680 (2.9%) 5230 (2.5%)
 80–89 1466 (1%) 540 (1.5%) 294 (1.2%) 2300 (1.1%)
 ≥ 90 929 (0.6%) 371 (1%) 207 (0.9%) 1507 (0.7%)
SAPS-II score
 Mean (SD) 33.5 (17.2) 37.7 (17.9) 36.1 (17.4) 34.5 (17.5)
 Median [Min, Max] 30 [0, 129] 35 [0, 118] 33 [0, 135] 31 [0, 135]
TISS EXT score sum
 Mean (SD) 127 (212) 128 (194) 116 (162) 126 (204)
 Median [Min, Max] 62 [1, 6150] 69 [2, 4270] 66 [2, 6120] 64 [1, 6150]
 Missing 176 (0.1%) 13 (0%) 9 (0%) 198 (0.1%)
Length of stay (days)
 Mean (SD) 3.05 (5.39) 3.28 (5.35) 2.91 (4.48) 3.07 (5.29)
 Median [Min, Max] 1.1 [0, 136] 1.6 [0.00139, 118] 1.6 [0.00625, 169] 1.22 [0, 169]
Outcome in hospital
 Survivor 132,204 (89.8%) 30,766 (84.7%) 19,997 (85%) 182,967 (88.3%)
 Non-survivor 15,047 (10.2%) 5577 (15.3%) 3540 (15%) 24,164 (11.7%)
Association of ICU-related factors with SRURs and SMR
In multivariable models, the following a priori selected 
ICU-related variables were significantly associated 
with decreased SRUR (RR estimates in Fig.  4): higher 
admissions/bed (all SRURs), independent organization 
(costSRURs), lower median SAPS-II (costSRURs) and 
Fig. 2 Changes over time in standardised mortality ratio (SMR) and standardised resource use ratios (SRUR LOS. SRUR TISS, costSRUR LOS, costSRUR TISS); 
box plots show the median, the first and third quartiles, and whiskers defined by 1.5 times the interquartile range; two-sided p value testing of no 
linear time trend: SRUR TISS (Overall population) p = 0.02, SMR (Overall population) p < 0.001
neurosurgery performed in hospital (costSRURs). Vari-
ables associated with increased SRUR were: higher SMR 
 (SRULOS, SRUR TISS, costSRUR TISS), readmissions/total 
admissions (all SRURs), nurses/physicians (costSRURs), 
and nurses/bed (costSRURs), specialist availability 24/7 
(costSRURs) and higher FTE physicians/bed (costSRURs) 
(RR and 95%CI in eTable 8).
In bivariable models, higher admissions/bed was sig-
nificantly associated with decreased SRUR (all SRURs), 
and the following variables were associated with 
increased SRUR: higher SMR  (SRULOS, SRUR TISS), and 
nurses/bed (costSRURs), specialist availability 24/7 
(SRUR TISS) and higher FTE physicians/bed (SRUR TISS).
Variables associated with increased SMR were cardiac 
surgery performed in hospital (only university hospi-
tals), independent organization (multivariable models) 
and small non-university ICUs (bivariable models), 
whereas neurosurgery performed in hospital (only uni-
versity hospitals) was associated with decreased SMR 
in bivariable models.
Fig. 3 Standardised resource use ratios (SRUR LOS, SRUR TISS) in relation to standardised mortality ratio (SMR) from 2008 to 2017. Filled circles: an ICU, 
circle size is proportional to the number of ICU admissions. Solid lines: Gaussian linear regression lines. Dashed lines: their 95% confidence intervals 
(slope estimates in eTable 4). Dotted horizontal and vertical lines: SRUR = 1 and SMR = 1
Fig. 4 Bivariable and multivariable analyses of variables associated with standardised resource utilization ratios (SRUR LOS, SRUR TISS, costSRUR LOS, 
costSRUR TISS) and standardised mortality ratio (SMR). The main finding was that higher number of admissions/bed was consistently associated with 
lower SRUR but not with SMR: A one SD increase in admissions/bed was associated with a reduction of SRUR LOS by 21.0%, 95% CI (27.1%, 14.4%), 
SRUR TISS by 19.9%, 95% CI (27.4%, 11.6%), costSRUR LOS by 22.5%, 95% CI (28.2%, 16.4%), costSRUR TISS by 21.9%, 95% CI (27.5%, 15.8%).; admissions/
bed was not significantly associated with SMR [effect estimate 2.0%, 95% CI (-8.2%, 5.5%)]. *Relative risk with 95% confidence intervals (values out-
side x-axis range are capped). Values > 1 indicate higher SRUR or SMR. The relative risk of 1.0 (dotted line) indicates an SRUR or SMR of 1. **reported 
variables adjusted for calendar year (bivariable), and in addition for all other listed variables (multivariable). Details for all variables in eTable8
Discussion
We provide in-depth information on ICU resources and 
costs needed to achieve hospital survivors in three Euro-
pean countries with different health care systems and 
wealth over 10 years. We adjusted for case mix between 
ICUs and for financial strength between countries to 
enhance comparability.
The main findings were:
(1) Severity-adjusted mortality (SMR) decreased over 
time, whereas the severity-adjusted resources needed 
to produce survivors (SRUR)—assessed using the 
surrogate indicators of LOS and TISS—remained 
unchanged or decreased.
(2) Differences between individual ICUs in both SRURs 
and SMR were up to > threefold, their evolution 
was highly variable, and there was no clear associa-
tion between SRUR and SMR; nevertheless, the cat-
egory small non-university ICUs was associated with 
increased SMR. Furthermore, the university ICUs 
had higher ranges of SRURs and lower ranges of 
SMRs than the non-university ICUs.
(3) The direct costs of ICU day, TISS score and ICU 
admission varied between the ICUs by 2.5–5-fold. 
The observed cost ranges agree with previous studies 
[16, 17].
The costs of producing hospital survivors increased 
exponentially with increased severity of illness and mor-
tality. This makes assessment of resource utilization using 
any cost components or outcomes meaningless without 
severity adjustment.
The ICUs’ severity-adjusted ability to produce hospi-
tal survivors, as reflected by SMR, the resources needed 
to produce survivors, and the distribution of severity of 
illness (case mix) are bound to interact. The concept of 
adjusting resource use for severity of illness was orig-
inally proposed by Rothen et  al. Using ICU LOS as a 
surrogate for resource use in 16,560 patients from 275 
ICUs from diverse health care systems and socioeco-
nomic conditions, SRUR LOS was found to vary much 
more than SMR (highest SRUR LOS ~ 30 and SMR ~ 3.6) 
[11]. Soares et  al. [12] observed lower variability of 
SRUR LOS (highest SRUR LOS ~ 6) in 59,693 patients from 
78 ICUs in Brazil. The present study on SRUR among 
ICUs in an established quality consortium is the larg-
est so far, and the first comparing LOS-based and 
TISS-based SRUR over time, as well as providing direct 
cost-based data. The variation of both SRUR and SMR 
was substantially smaller in our study, with SRUR LOS, 
SRUR TISS and SMR ranging from ~ 0.6 to 1.8 and cost-
SRUR LOS and costSRUR TISS from ~ 0.7 to 2.7 and corre-
sponding SMR of ~ 0.6 to 1.5. This variation is still high, 
especially since about 2/3 of the admissions were from 
one country with homogenous health care system, but 
substantially lower than the variation in direct costs/
admission and direct costs/survivor.
Due to the lack of association between SRURs and 
SMR, these should be used together to evaluate ICU per-
formance. For example, the wider range of SRURs in the 
university ICUs versus the wider range of SMRs in the 
non-university ICUs suggests the need to focus on cost 
containment in the university ICUs, and on higher qual-
ity care in terms of severity-adjusted outcomes in the 
non-university ICUs.
Low SRUR combined with low SMR should provide the 
best results of outcome and costs. SMR is widely used 
to assess ICU performance. With increasing demand to 
control health care costs without compromising quality, 
combining SRUR with SMR offers obvious advantages. 
Severity adjustment of both resource use and outcomes 
may also be helpful in cost-efficiency studies [16, 18]. 
Ideally, resource use indicators should be convertible to 
costs, but differences in cost accounting, allocation, and 
budgeting can be major barriers. The surrogate resource 
use indicators SRUR LOS and SRUR TISS correlated well 
with the corresponding cost-based SRUR, suggesting that 
in the absence of sufficient direct costs data, SRUR LOS 
and SRUR TISS provide comparable information. SRUR as 
concept has the potential to be adapted to other health 
care settings, where indices of illness severity and costs 
or their surrogates are available. This could facilitate the 
evaluation of resources needed to care and rehabilitate 
post-ICU disabilities.
High patient turnover was the main variable associ-
ated with low SRUR. This may sound self-evident, but it 
has not been verified in the context of severity-adjusted 
costs and outcomes. High turnover with short LOS can 
be associated with either low severity of illness, high risk 
of readmissions with poor outcome, or both. We found 
an association between high turnover and lower SRUR 
without an association with SMR. That is, a higher num-
ber of admissions/bed was not associated with worse 
outcome but was associated with reduced resource use, 
both adjusted for severity of illness. Measures to safely 
increase patient turnover may include changes in clini-
cal practice (e.g. sedation, mobilization, weaning from 
ventilation, hemodynamic management) and process 
measures (e.g. daily routines in decision making, bed 
availability for discharge, enhanced intermediate care 
capacity).
High patient turnover may also cause strain and lead 
to worsening outcomes. We did not have the data to 
assess strain. The annual mean bed occupation rates were 
always below 80%, and in most ICUs below 60% (eFig-
ure  11), making strain unlikely. The lack of association 
between number of admissions/bed and SMR suggests 
that strain, if present, had no major impact on SMR.
Increased nurses/bed and physicians/bed increased 
the costSRURs without an impact on SMR. In terms of 
absolute staff numbers, all participating units were well 
staffed and the nurses/bed (median 0.83 or 1:1.2) exceeds 
the threshold associated with decreased mortality [19]. 
The relevance of specialist availability 24/7 is controver-
sial [19, 20]. Our results suggest that specialist availabil-
ity 24/7 increases costs but has no consistent impact on 
SMR.
The association between an independent organiza-
tion and increased SMR needs to be interpreted with 
caution. Independent organization was present in five 
of eight university ICUs and in one large non-university 
ICU. ICU category was not included in the multivariable 
model due to its high correlation with other variables. 
We, therefore, suspect that case-mix differences between 
ICU categories are likely to contribute.
Many ICU consortia world-wide collect data on SMR 
and other quality indicators [7, 8, 10, 12, 13]. SRUR using 
either surrogates or direct costs if available, can be incor-
porated relatively easily in such data sets, especially when 
electronic patient data management systems (PDMS) and 
medical records are available. We believe that the parallel 
use of SRUR and SMR can provide relevant information 
for all intensive care stakeholders.
Our study has several strengths. These include stand-
ardized and validated data acquisition with extensive log-
ical controls, use of electronic patient data management 
systems in all but one center, clear allocation of direct 
costs, large database with very few missing data, inclu-
sion of > 90% of the ICU admissions in Finland and of 
two large university hospitals in countries with different 
health care systems and wealth, and cost adjustment to 
PPP. The limitations should also be considered. Only uni-
versity ICUs from outside Finland were included and they 
represented 33–100% university ICU admissions in Swit-
zerland and Estonia, respectively. Their results should not 
be considered as representative of ICU practices of these 
countries in general. Although most ICUs had their own 
budgets, physicians’ salaries were often partly allocated 
to other budgets, due to tasks shared between ICUs and 
others, especially in the non-university ICUs. We used 
time-based consensus for the allocation of these costs, 
using average ICU physician salaries as reference. These 
potential inaccuracies still represent a small minority of 
the direct costs and should not cause relevant bias. Thus, 
we consider our findings as reliable and generalizable for 
intensive care in high-income countries.
In conclusion, our findings demonstrate wide and 
independent variation in both SMR and SRUR. SMR 
and SRUR should, therefore, be used together to 
compare performance of different ICUs or an individ-
ual ICU over time. The parallel use of SMR and SRUR 
may provide relevant information for all stakeholders 
involved in intensive care.
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